Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsTransplantation, AutologousStem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ChimeraGranulocyte Colony-Stimulating FactorGraft SurvivalBusulfanBone Marrow TransplantationTissue DonorsAntigens, CD34VidarabineTreatment OutcomeLeukapheresisRecurrenceMyeloablative AgonistsGraft vs Leukemia EffectImmunosuppressive AgentsStem CellsMelphalanCombined Modality TherapyHistocompatibility TestingMultiple MyelomaHematopoietic Stem CellsRemission InductionHistocompatibilityRetrospective StudiesCyclophosphamideCord Blood Stem Cell TransplantationSurvival AnalysisLeukemiaBlood Component RemovalWhole-Body IrradiationAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalLeukemia, Myeloid, AcuteSalvage TherapyLymphoma, Non-HodgkinSurvival RatePrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Tumor EffectEtoposideCytomegalovirus InfectionsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte TransfusionMyelodysplastic SyndromesChronic DiseaseAntineoplastic Agents, AlkylatingHLA AntigensLymphocyte DepletionTransplantation, IsogeneicInfectionTime FactorsLiver TransplantationT-LymphocytesThiotepaCytarabineAnemia, AplasticHodgkin DiseaseSiblingsPOEMS SyndromeHematopoiesisNeoplasm, ResidualTransplantation ImmunologyVincristineFollow-Up StudiesCyclosporineHematologic DiseasesMesenchymal Stem Cell TransplantationAntilymphocyte SerumAmyloidosisImmunosuppressionCarmustineFatal OutcomeLymphomaBlood CellsCell TransplantationOpportunistic InfectionsAcute DiseaseKidney TransplantationIfosfamidePrognosisChimerismEmbryonic Stem CellsHepatic Veno-Occlusive DiseaseMinor Histocompatibility AntigensAntineoplastic AgentsBone MarrowPlatelet CountProspective StudiesImmunophenotypingVirus ActivationNeoplasmsBlood DonorsFeasibility Studies